Cardiol Therapeutics Inc.
NASDAQ:CRDL
1.83 (USD) • At close October 29, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 34.932 | 59.47 | 83.899 | 14.025 | 6.956 | 16.732 | 2.357 |
| Short Term Investments
| 0.062 | 0.062 | 0.062 | 0.062 | 0.061 | 0 | 0 |
| Cash and Short Term Investments
| 34.932 | 59.47 | 83.899 | 14.025 | 6.956 | 16.732 | 2.357 |
| Net Receivables
| 0.28 | 0.48 | 0.407 | 0.22 | 0.928 | 0.461 | 0.102 |
| Inventory
| -0.28 | 0 | 0 | 0.018 | 1.119 | 6.346 | 0 |
| Other Current Assets
| 0.28 | 1.488 | 2.834 | 0.687 | 5.368 | 0.489 | 0.027 |
| Total Current Assets
| 36.153 | 61.438 | 87.14 | 14.95 | 14.371 | 24.027 | 2.485 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 0.337 | 0.296 | 0.356 | 0.48 | 0.584 | 0.026 | 0.019 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0.21 | 0.295 | 0.379 | 0.464 | 0.548 | 0.633 | 0.717 |
| Goodwill and Intangible Assets
| 0.21 | 0.295 | 0.379 | 0.464 | 0.548 | 0.633 | 0.717 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | -0 | -0 | 0 | -0 | 0 | 0 |
| Total Non-Current Assets
| 0.547 | 0.591 | 0.736 | 0.943 | 1.132 | 0.658 | 0.736 |
| Total Assets
| 36.701 | 62.029 | 87.876 | 15.893 | 15.503 | 24.685 | 3.221 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 7.625 | 8.349 | 4.188 | 1.77 | 0.561 | 2.141 | 0.177 |
| Short Term Debt
| 0.016 | 0.05 | 0.045 | 0.052 | 0.05 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| -7.625 | -8.349 | -4.188 | -1.77 | -0.561 | 0 | 0 |
| Other Current Liabilities
| 8.28 | 9.754 | 11.52 | 2.466 | 0.64 | 0 | 0 |
| Total Current Liabilities
| 8.295 | 9.805 | 11.565 | 2.518 | 0.691 | 2.141 | 0.177 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0.159 | 0.022 | 0.073 | 0.105 | 0.14 | 0.269 | 0.19 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | -0 | -0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 0.159 | 0.022 | 0.073 | 0.105 | 0.14 | 0.269 | 0.19 |
| Total Liabilities
| 8.454 | 9.827 | 11.638 | 2.623 | 0.831 | 2.411 | 0.367 |
| Equity: | |||||||
| Preferred Stock
| 18.786 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 148.519 | 147.545 | 142.919 | 51.923 | 39.414 | 36.722 | 4.255 |
| Retained Earnings
| -142.576 | -114.449 | -83.518 | -51.88 | -31.239 | -17.555 | -1.661 |
| Accumulated Other Comprehensive Income/Loss
| 3.518 | 3.518 | 4.177 | 4.461 | 1.731 | 1.853 | 0.259 |
| Other Total Stockholders Equity
| -0.001 | 15.587 | 12.66 | 8.766 | 4.766 | 1.253 | 0 |
| Total Shareholders Equity
| 28.247 | 52.202 | 76.238 | 13.27 | 14.672 | 22.274 | 2.854 |
| Total Equity
| 28.247 | 52.202 | 76.238 | 13.27 | 14.672 | 22.274 | 2.854 |
| Total Liabilities & Shareholders Equity
| 36.701 | 62.029 | 87.876 | 15.893 | 15.503 | 24.685 | 3.221 |